These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36809998)

  • 21. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats.
    Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
    Fiume L; Bolondi L; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Di Stefano G
    J Hepatol; 2005 Oct; 43(4):645-52. PubMed ID: 16023760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piperlongumine inhibits diethylnitrosamine induced hepatocellular carcinoma in rats.
    Kumar A; Naithani M; Kumar N; Singh N; Agrawal S; Sharma A; Thapliyal S; Singh J; Handu S
    Hum Exp Toxicol; 2022; 41():9603271211073593. PubMed ID: 35113675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
    Lo SJ; Fan LC; Tsai YF; Lin KY; Huang HL; Wang TH; Liu H; Chen TC; Huang SF; Chang CJ; Lin YJ; Yung BY; Hsieh SY
    Hepatology; 2013 May; 57(5):1893-905. PubMed ID: 23258611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effect of carnosine in rat model of experimental liver carcinogenesis.
    Fouad AA; Qutub HO; Al Rashed AS; Al-Melhim WN
    Environ Toxicol Pharmacol; 2017 Dec; 56():10-14. PubMed ID: 28863318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatoprotective, antioxidant and anti-inflammatory potentials of Vit-E/C@SeNPs in rats: Synthesis, characterization, biochemical, radio-biodistribution, molecular and histopathological studies.
    Aljuhr SA; Abdelaziz G; Essa BM; Zaghary WA; Sakr TM
    Bioorg Chem; 2021 Dec; 117():105412. PubMed ID: 34649153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.
    Giovannini C; Gramantieri L; Chieco P; Minguzzi M; Lago F; Pianetti S; Ramazzotti E; Marcu KB; Bolondi L
    J Hepatol; 2009 May; 50(5):969-79. PubMed ID: 19304334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Protective Role of Etoricoxib Against Diethylnitrosamine/2-acetylaminofluorene- Induced Hepatocarcinogenesis in Wistar Rats: The Impact of NF-κB/COX-2/PGE2 Signaling.
    Ali G; Omar H; Hersi F; Abo-Youssef A; Ahmed O; Mohamed W
    Curr Mol Pharmacol; 2022; 15(1):252-262. PubMed ID: 34238176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade.
    Mo'men YS; Hussein RM; Kandeil MA
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):322-332. PubMed ID: 31663622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer Effects of Tacrolimus on Induced Hepatocellular Carcinoma in Mice.
    Mahmoud SS; Hussein S; Rashed H; Abdelghany EMA; Ali AI
    Curr Mol Pharmacol; 2022; 15(2):434-445. PubMed ID: 34061012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.
    Miao R; Xu X; Wang Z; Liu S; Qu K; Chen W; Liu C
    Mol Med Rep; 2018 Mar; 17(3):3735-3743. PubMed ID: 29286113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenolics-Enriched Fraction of
    Pal LC; Prateeksha ; Singh BN; Pande V; Rao CV
    Nutr Cancer; 2022; 74(3):1106-1121. PubMed ID: 34018459
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Moawed FS; Haroun RA; Abou Zaid ES; Mansour SZ; Badawi AM; Kandil EI
    Int J Immunopathol Pharmacol; 2023; 37():3946320231180708. PubMed ID: 37276131
    [No Abstract]   [Full Text] [Related]  

  • 35. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aidi injection enhances the anti-tumor impact of doxorubicin in H22 tumor-containing mice.
    Lu Y; Zhang S; Zhu X; Wang K; He Y; Liu C; Sun J; Pan J; Zheng L; Liu W; Li Y; Huang Y; Liu T
    J Ethnopharmacol; 2023 Mar; 303():115968. PubMed ID: 36473617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
    Abdel-Hamid NI; El-Azab MF; Moustafa YM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin K analog (compound 5) induces apoptosis in human hepatocellular carcinoma independent of the caspase pathway.
    Enokimura N; Shiraki K; Kawakita T; Saitou Y; Inoue H; Okano H; Yamamoto N; Sugimoto K; Carr BI; Nakano T
    Anticancer Drugs; 2005 Sep; 16(8):837-44. PubMed ID: 16096431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
    Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
    Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
    BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.